328 related articles for article (PubMed ID: 1677569)
21. PAK-104P, a pyridine analogue, reverses paclitaxel and doxorubicin resistance in cell lines and nude mice bearing xenografts that overexpress the multidrug resistance protein.
Vanhoefer U; Cao S; Minderman H; Tóth K; Scheper RJ; Slovak ML; Rustum YM
Clin Cancer Res; 1996 Feb; 2(2):369-77. PubMed ID: 9816180
[TBL] [Abstract][Full Text] [Related]
22. The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells.
Fu LW; Zhang YM; Liang YJ; Yang XP; Pan QC
Eur J Cancer; 2002 Feb; 38(3):418-26. PubMed ID: 11818209
[TBL] [Abstract][Full Text] [Related]
23. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
[TBL] [Abstract][Full Text] [Related]
24. Adriamycin resistance in human tumor cells associated with marked alteration in the regulation of the hexose monophosphate shunt and its response to oxidant stress.
Yeh GC; Occhipinti SJ; Cowan KH; Chabner BA; Myers CE
Cancer Res; 1987 Nov; 47(22):5994-9. PubMed ID: 3664503
[TBL] [Abstract][Full Text] [Related]
25. Reduced topoisomerase II and elevated alpha class glutathione S-transferase expression in a multidrug resistant CHO cell line highly cross-resistant to mitomycin C.
Hoban PR; Robson CN; Davies SM; Hall AG; Cattan AR; Hickson ID; Harris AL
Biochem Pharmacol; 1992 Feb; 43(4):685-93. PubMed ID: 1311588
[TBL] [Abstract][Full Text] [Related]
26. Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells.
Schuurhuis GJ; van Heijningen TH; Cervantes A; Pinedo HM; de Lange JH; Keizer HG; Broxterman HJ; Baak JP; Lankelma J
Br J Cancer; 1993 Nov; 68(5):898-908. PubMed ID: 8105865
[TBL] [Abstract][Full Text] [Related]
27. Relationships among tumor responsiveness, cell sensitivity, doxorubicin cellular pharmacokinetics and drug-induced DNA alterations in two human small-cell lung cancer xenografts.
Pratesi G; Capranico G; Binaschi M; De Isabella P; Pilotti S; Supino R; Zunino F
Int J Cancer; 1990 Oct; 46(4):669-74. PubMed ID: 1976600
[TBL] [Abstract][Full Text] [Related]
28. Role of oxygen free radical formation in the mechanism of menogaril resistance in multidrug resistant tumor cells.
Sinha BK; Atwell J; Politi PM
Chem Biol Interact; 1990; 76(1):89-99. PubMed ID: 2168296
[TBL] [Abstract][Full Text] [Related]
29. Radiation-induced damage to DNA in drug- and radiation-resistant sublines of a human breast cancer cell line.
Alaoui-Jamali MA; Batist G; Lehnert S
Radiat Res; 1992 Jan; 129(1):37-42. PubMed ID: 1728055
[TBL] [Abstract][Full Text] [Related]
30. Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells.
Nakagawa M; Schneider E; Dixon KH; Horton J; Kelley K; Morrow C; Cowan KH
Cancer Res; 1992 Nov; 52(22):6175-81. PubMed ID: 1358431
[TBL] [Abstract][Full Text] [Related]
31. Glutathione, glutathione S-transferases, and related redox enzymes in Adriamycin-resistant cell lines with a multidrug resistant phenotype.
Schisselbauer JC; Crescimanno M; D'Alessandro N; Clapper M; Toulmond S; Tapiero H; Tew KD
Cancer Commun; 1989; 1(2):133-9. PubMed ID: 2639724
[TBL] [Abstract][Full Text] [Related]
32. Glutathione depletion in human and in rat multi-drug resistant breast cancer cell lines.
Batist G; Schecter R; Woo A; Greene D; Lehnert S
Biochem Pharmacol; 1991 Feb; 41(4):631-5. PubMed ID: 1997009
[TBL] [Abstract][Full Text] [Related]
33. Correlation between functional and molecular analysis of mdr1 P-glycoprotein in human solid-tumor xenografts.
Broxterman HJ; Feller N; Kuiper CM; Boven E; Versantvoort CH; Teerlink T; Pinedo HM; Lankelma J
Int J Cancer; 1995 Jun; 61(6):880-6. PubMed ID: 7790125
[TBL] [Abstract][Full Text] [Related]
34. Doxorubicin-induced oxygen free radical formation in sensitive and doxorubicin-resistant variants of rat glioblastoma cell lines [corrected and republished erratum originally printed in FEBS Lett 1993 May 17;322(3):295-8].
Benchekroun MN; Sinha BK; Robert J
FEBS Lett; 1993 Jul; 326(1-3):302-5. PubMed ID: 8392002
[TBL] [Abstract][Full Text] [Related]
35. Glutathione S-transferases in wild-type and doxorubicin-resistant MCF-7 human breast cancer cell lines.
Wang K; Ramji S; Bhathena A; Lee C; Riddick DS
Xenobiotica; 1999 Feb; 29(2):155-70. PubMed ID: 10199592
[TBL] [Abstract][Full Text] [Related]
36. Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cells: implications for the mechanism of action.
Sinha BK; Katki AG; Batist G; Cowan KH; Myers CE
Biochemistry; 1987 Jun; 26(13):3776-81. PubMed ID: 2820475
[TBL] [Abstract][Full Text] [Related]
37. Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs.
Gouazé V; Liu YY; Prickett CS; Yu JY; Giuliano AE; Cabot MC
Cancer Res; 2005 May; 65(9):3861-7. PubMed ID: 15867385
[TBL] [Abstract][Full Text] [Related]
38. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
39. Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line.
Hill AB; Beck WT; Trent JM
Cancer Res; 1988 Jan; 48(2):393-8. PubMed ID: 2891436
[TBL] [Abstract][Full Text] [Related]
40. Expression of mdr1 and gst-pi in human breast tumours: comparison to in vitro chemosensitivity.
Keith WN; Stallard S; Brown R
Br J Cancer; 1990 May; 61(5):712-6. PubMed ID: 1970934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
